PMA device
ReShape Integrated Dual Balloon System
Boston Scientific Corporation · Implant, Intragastric For Morbid Obesity (LTI, Class III) · First FDA decision Dec 21, 2015, newest May 30, 2018Obesity
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
1
Naming "ReShape Integrated Dual"
MAUDE reports
99
Brand "ReShape Integrated Dual", since 2015
PubMed studies
0
Mentioning "ReShape Integrated Dual"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ReShape Integrated Dual Balloon System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- ReShape Integrated Dual Balloon SystemPMA supplement
P140012-S012 · Decided May 30, 2018 · 93 days after receipt · Normal 180 Day Track No User Fee
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
- ReShape Integrated Dual Ballon SystemPMA supplement
P140012-S010 · Decided Jun 27, 2017 · 60 days after receipt · Normal 180 Day Track No User Fee
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
- RESHAPE INTEGRATED DUAL BALLOON SYSTEM,RESHAPE BALLOON ASSEMBLY,RESHAPE REMOVAL CATHETER,RESHAPE VALVE SEALANTPMA supplement
P140012-S002 · Decided Dec 21, 2015 · 84 days after receipt · Normal 180 Day Track
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Bariatric Surgery for the Treatment of Morbid Obesity - Facility Certification RequirementNational analysisReview closedCAG-00250R3Updated Sep 16, 2026
- Bariatric Surgery for the Treatment of Morbid ObesityNational analysisReview closedCAG-00250R2Updated Sep 16, 2026
- Bariatric Surgery for the Treatment of Morbid ObesityNational analysisReview closedCAG-00250RUpdated Sep 16, 2026
- Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid ObesityNational determinationOn the books100.1Updated Apr 9, 2025
- Bariatric Surgical Management of Morbid ObesityLocal determinationIn effectL35022Novitas Solutions, Inc.Updated May 7, 2021
- Surgical Management of Morbid ObesityLocal determinationIn effectL33411First Coast Service Options, Inc.Updated Oct 2, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "ReShape Integrated Dual", any status and sponsor, newest update first.
- A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese SubjectsStatus unknown
ReShape LifesciencesNot on our public-company list
NCT02927665 · 186 participants · Start Sep 2016 · Primary completion Nov 2019
Device: Reshape Integrated Dual Balloon · For: Obesity
Sites: Dothan, Alabama; Newark, Delaware; Barrington, Illinois · 14 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ReShape Integrated Dual", and for the whole product code for context.
This brand
99 reports: 29 malfunction, 67 injury, 3 death
Whole product code LTI
5,233 reports: 2,779 malfunction, 2,372 injury, 70 death
Newest reports for this brand
3006722112-2020-00041 · Received Mar 25, 2020 · Event dated Nov 12, 2018
Device type: Implant, Intragastric For Morbid Obesity (LTI)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pain; Sepsis; Patient Problem/Medical Problem
- RESHAPE INTEGRATED DUAL BALLOON SYSTEMMalfunction
3006722112-2019-00194 · Received Dec 10, 2019 · Event dated Oct 16, 2019
Device type: Implant, Intragastric For Morbid Obesity (LTI)
Device problem as coded: Deflation Problem
Patient problem as coded: Pain
- RESHAPE INTEGRATED DUAL BALLOON SYSTEMMalfunction
3006722112-2019-00502 · Received May 23, 2019 · Event dated Apr 25, 2019
Device type: Implant, Intragastric For Morbid Obesity (LTI)
Device problem as coded: Fluid/Blood Leak
Patient problem as coded: Failure of Implant
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ReShape Integrated Dual"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LTI.
- Lap-Band Adjustable Gastric Banding SystemMedtimo, Inc. · PMA 2023
- Obalon Balloon SystemMedtimo, Inc. · PMA 2022
- Orbera Intragastric BalloonBoston Scientific Corporation · PMA 2026
- Bioenterics Lap-Band Adjustable Gastric Banding SystemMedtimo, Inc. · PMA 2003
- Allurion Gastric Balloon SystemAllurion Technologies, Inc. · PMA 2026
- Spatz3 Adjustable Balloon SystemSpatz Fgia, Inc. · PMA 2023
- Ethicon Endo-Surgery Curved Adjustable Gastric with Sutureless Port and ApplierObtech Medical GmbH · PMA 2016
- Realize Adjustable Gastric BandObtech Medical GmbH · PMA 2011
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.